Molecular Horizon

Molecular Horizon is an innovative startup founded in 2017 in Bettona, Italy, that specializes in IT solutions and data strategy design for chemistry, pharmaceutical chemistry, and biotechnology. The company integrates three core research lines: platform design and development for data storage, query, and chemical property prediction via cloud computing; lipidomics and medicinal chemistry for the discovery of novel compounds; and drug design and molecular modeling for in silico receptor modeling and virtual screening. Additionally, they provide consultancy in chemometrics and experimental services for metabolic stability, impurity detection, and structural identification. The company also develops specialized software, such as Pyxis, which is designed for ion mobility mass spectrometry imaging data analysis.

These capabilities support pharmaceutical and biotech researchers by addressing complex challenges in drug discovery and digital health. Through a highly specialized team, Molecular Horizon collaborates in national and international research consortia, contributing to projects such as anti-coronavirus initiatives and metabolic disease research. By combining expertise in life sciences with advanced computational and artificial intelligence approaches, the company assists partners in optimizing drug development pipelines, improving 3D medical imaging interpretation, and advancing precision medicine through innovative therapeutic solutions.